A phase II study of sequential velcade/thalidomide/dexamethasone as maintenance therapy post single autologous peripheral stem cell in patients with multiple myeloma

被引：0
|
作者：
Sahebi, F. [1 ]
机构：
[1] City Hope Natl Med Ctr, Duarte, CA 91010 USA
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S148 / S148
页数：1
相关论文
共 50 条
  • [31] RESULTS OF AUTOLOGOUS PERIPHERAL HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH MULTIPLE MYELOMA WITHOUT MAINTENANCE THERAPY
    Jusupova, Sh. K.
    LEUKEMIA RESEARCH, 2014, 38 : S26 - S26
  • [32] Phase II Study of Iberdomide Maintenance Therapy Post-Autologous Stem Cell Transplant in Multiple Myeloma: Results of a Planned Interim Analysis
    Wildes, Tanya
    Suman, Vera Jean
    Strege, Marnee
    Tario, Joseph
    Holstein, Sarah
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S32 - S32
  • [33] Thalidomide maintenance after autologous stem cell transplantation for multiple myeloma.
    Grosskreutz, CL
    Egan, R
    Scigliano, E
    Fruchtman, SM
    Isola, LM
    BLOOD, 2003, 102 (11) : 489B - 490B
  • [34] A phase II study of thalidomide plus bolus vincristine/adriamycin and modified dexamethasone combination therapy followed by autologous stem cell transplantation for multiple myeloma: Preliminary data
    Jo, J.-Ch.
    Kim, S.
    Kang, B. W.
    Lee, S. S.
    Sym, S. J.
    Jang, G. D.
    Suh, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 541 - 541
  • [35] Response of Velcade Dexamethasone Thalidomide (VTD) Chemotherapy in patients suitable for Autologous Stem Cell transplant in Myeloma; experience of District General Hospital
    Vijayenthiran, H.
    Wenban, C.
    Careless, A.
    Stimson, L.
    Ahmad, H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 181 - 181
  • [36] Thalidomide, Cyclophosphamide and Dexamethasone Induction Therapy: Feasibility for Myeloma Patients Destined for Autologous Stem Cell Transplantation
    Chang, Won Jin
    Kang, Eun-Suk
    Lee, Seung-Tae
    Kim, Sun-Hee
    Kim, Dae Won
    Kim, Seok Jin
    Kim, Kihyun
    ACTA HAEMATOLOGICA, 2014, 132 (02) : 226 - 232
  • [37] Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
    Cavo, Michele
    Pantani, Lucia
    Petrucci, Maria Teresa
    Patriarca, Francesca
    Zamagni, Elena
    Donnarumma, Daniela
    Crippa, Claudia
    Boccadoro, Mario
    Perrone, Giulia
    Falcone, Antonietta
    Nozzoli, Chiara
    Zambello, Renato
    Masini, Luciano
    Furlan, Anna
    Brioli, Annamaria
    Derudas, Daniele
    Ballanti, Stelvio
    Dessanti, Maria Laura
    De Stefano, Valerio
    Carella, Angelo Michele
    Marcatti, Magda
    Nozza, Andrea
    Ferrara, Felicetto
    Callea, Vincenzo
    Califano, Catello
    Pezzi, Annalisa
    Baraldi, Anna
    Grasso, Mariella
    Musto, Pellegrino
    Palumbo, Antonio
    BLOOD, 2012, 120 (01) : 9 - 19
  • [38] Thalidomide, dexamethasone, Doxil and Velcade (ThaDD-V) followed by consolidation/maintenance therapy in patients with relapsed-refractory multiple myeloma
    Offidani, Massimo
    Corvatta, Laura
    Polloni, Claudia
    Gentili, Silvia
    Mele, Anna
    Rizzi, Rita
    Catarini, Massimo
    Caraffa, Patrizia
    Samori, Arduino
    Blasi, Nicola
    Ferranti, Mario
    Malerba, Lara
    Brunori, Marino
    Leoni, Pietro
    ANNALS OF HEMATOLOGY, 2011, 90 (12) : 1449 - 1456
  • [39] EFFECTIVENESS OF THE VELCADE-THALIDOMIDE-DEXAMETHASONE SCHEME WITH LOW DOSE THALIDOMIDE IN PATIENTS WITH MULTIPLE MYELOMA CANDIDATES TO AUTOLOGOUS HEMATOPOYETIC PROGENITOR TRANSPLANTATION
    Martinez Garcia, A. B.
    Romera Martinez, M.
    Meca Maestre, Gutierrez D.
    Cabanas Perianes, V
    Martinez Marin, A.
    Moya Arnao, M.
    Martinez Frances, A.
    HAEMATOLOGICA, 2017, 102 : 95 - 95
  • [40] Update of a Phase II Study of Lenalidomide-Elotuzumab As Maintenance Therapy Post-Autologous Stem Cell Transplant (AuSCT) in Patients (Pts) with Multiple Myeloma (MM)
    Thomas, Sheeba K.
    Shah, Jatin J.
    Morin, Armando
    Morphey, Ashley N.
    Lee, Hans C.
    Manasanch, Elisabet E.
    Patel, Krina K.
    Kaufman, Gregory P.
    Iyer, Swami P.
    Feng, Lei
    Amini, Behrang
    Qazilbash, Muzaffar H.
    Bashir, Qaiser
    Saini, Neeraj
    Srour, Samer A.
    Johnson, Ralph J.
    Crumpton, Brandon N.
    Stafford, Mildred D.
    Weber, Donna M.
    Orlowski, Robert Z.
    BLOOD, 2020, 136
12345